Autori: Milella Michele
| Naslov | Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer. (Meeting Abstract) |
| Autori | Van Cutsem Eric Hidalgo Manuel Bazin Igor Canon Jean-Luc Poddubskaya Elena Manojlovic Nebojsa S Milella Michele Radenkovic Dejan V Verslype Chris Guo Wei Damstrup Lars Hammel Pascal |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2015), vol. 33 br. 3, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response. (Article) |
| Autori | McCubrey James A Steelman Linda S Chappell William H Abrams Stephen L Montalto Giuseppe Cervello Melchiorre Nicoletti Ferdinando Fagone Paolo Malaponte Graziella Mazzarino Maria C Candido Saverio Libra Massimo Baesecke Joerg Mijatovic Sanja A Maksimovic-Ivanic Danijela D Milella Michele Tafuri Agostino Cocco Lucio Evangelisti Camilla Chiarini Francesca Martelli Alberto M |
| Info | ONCOTARGET, (2012), vol. 3 br. 9, str. 954-987 |
| Projekat | Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca (Ministry for Education, Universities and Research) - MIUR" [n. RBNE08YYBM]; CNR from Italian Ministry of Economy and Finance for the Project FaReBio di Qualita; MIUR [RBAP10447J-003, RBA |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
